Biotech and Money New York 2015 conference page

17 November 2015, TKP New York Conference Center, New York

Slide background

ABOUT BIOTECH AND MONEY NEW YORK AND HEALTHEX

Register now and save $$$s.

Biotech and Money New York and HealthEx New York are co-located events that aim to shine a light on New York's life science eco-system, helping promote NYC as a centre for life science excellence. It's where life science meets money, investors meet deal flow and industry promote strategic collaborations.

Biotech and Money New York ​is ​a ​one-day ​congress ​which ​aims ​to ​provide ​genuine ​peer ​2 ​peer ​knowledge ​sharing, ​networking ​and ​deal ​making ​opportunities ​between ​CxO ​level ​executives, ​and ​uncover ​new ​ideas ​to ​move ​the ​industry ​forward. ​At ​its ​heart ​is ​a ​mission ​to ​promote ​NYC ​and ​the ​region ​as ​a ​centre ​for ​life ​science ​excellence, ​help ​build ​linkages, ​partnership ​and ​collaboration ​opportunities ​between ​life ​science ​companies, ​pharma ​and ​capital, ​but ​also ​help ​connect ​the ​stellar ​UK ​companies ​and ​CEOs ​in ​Biotech ​and ​Money’s ​network ​with ​US ​partners ​and ​opportunities. ​View the agenda at a glance or Download the Preview Brochure in full.

HealthEx New York is ​an ​invite ​only ​closed ​door ​Chatham ​House ​Rules ​Listed ​Forum ​for ​CEOs, ​CFOs, ​Chairmen ​and ​NEDs ​of ​publicly ​listed ​companies. ​This ​forum ​allows ​high ​level ​debate ​on ​such ​topics ​that ​include ​growth ​strategies, ​capital ​markets ​and ​Innovative ​financing ​strategies, ​M&A ​and ​deal ​structures, ​navigating ​the ​regulatory ​and ​legislative ​framework ​and ​areas ​of ​sector ​collaboration. ​Attendance ​is ​limited ​to ​75 ​participants ​that ​meet ​the ​eligibility ​criteria. Learn more about HealthEx NYC. 

Keynote Sessions

- New York City as a life sciences powerhouse
- Accelerating translation and encouraging collaboration
- Deal making, M&A; and beyond: life is a big deal
- Funding the next half a century of drugs and life science tech
- What’s hot and what’s not in life sciences

Start-Up / Early Stage

- Spurring early stage venture funding and financing
- Corporate venture: where is the real value add?
- When Pharma comes knocking: early stage collaborative models
- How to value and protect your IP
- How to engage Angel / Seed funders
- How to effectively use debt financing
- How to raise investment through crowd funding
- How to receive funding from non-dilutive sources

Growth / Later Stage

- Meeting the demands of later stage venture capital
- Filling the gap through venture philanthropy
- Licensing agreements: upfront payments, milestones and royalties
- Tales from the road: successful private financing deals
- News from the street and 2016 IPO outlook

HealthEx Listed CEO Forum

These sessions are for CEOs and CFOs of listed life science companies only.

- How and where will you grow?
- Creating and unlocking value
- Capital markets and innovative financing strategies
- Investor engagement, education and communication
- Value and access evolving and shaping strategic opportunities

Exclusive audience

A qualified executive-level audience.

Heavy buy-side dynamic. Sell side represents <10% of the audience.

We keep the profile dynamic focused on life science and money.

New formats

We don't do power point.

Peer-to-peer formats to share knowledge and experience.

Content that offers both strategic and practical take aways.

New players

We attract grass root investors, innovators and entrepreneurs.

We develop sessions for companies in any stage of their funding / investment lifecycle.

Keynote Panels

60 min sessions from life science pioneers. No powerpoint.

Inspirational, thought provoking, game changing content and discussion.

Roundtables

40 min roundtables on specific industry challenges and opportunities.

Intimate, immersive and interactive.

Gain genuine practical advice.

Group discussions

45 min themed discussion groups on key elements of the funding lifecycle.

Genuine executive level peer-to-peer debate, discussion and outcomes.

Online showcases

We offer elevator pitches to attending life science companies.

We give portal access to Investors and Pharma to help them with S&E.;

1-2-1 partnering

1-2-1 Partnering system to search, evaluate and arrange onsite meetings.

Formal sessions to meet your next client and develop business relationships.

Networking

In addition to the 1-2-1 partnering system we offer two networking drinks receptions, taking place on the pre-conference day and at the close of day one.

Who Attends

Executive level stakeholders from the following profiles benefit from participating:

  • - Pre-seed entrepreneurs and CEO-designates
  • - Pre-revenue and SME life science 
  • - Mid Cap private and publicly listed life science
  • - Large Cap Biotech and Pharma
  • - Angels, VCs, PE, CVCs, Institutional and Specialist Investors / Funds
  • - Government Bodies
  • - Financial / Professional Services

Who Partners

Companies from the following profiles will benefit from taking sponsoring platforms:

  • - Large Biotech / Large Pharma
  • - Law Firms / Patent Attorneys / IP Firms
  • - Global Consultant / Advisory
  • - Investment Banks / Brokers
  • - Venture Capital / Funds
  • - Corporate Venture
  • - TTOs
  • - Trade Associations

Reasons to Partner

Obvious benefits and outcomes of partnering include:

  • - Demonstrate Thought Leadership
  • - Raise Corporate Profile
  • - Educate and Share Expertise
  • - Generate Brand Awareness
  • - Align your Corporate Brand
  • - Generate Business Leads

LEAD PARTNER

STRATEGIC PARTNER

HOST PARTNER

GOLD PARTNER

SILVER PARTNER

SILVER PARTNER

ASSOCIATE PARTNER

ASSOCIATE PARTNER

ASSOCIATE PARTNER

SUPPORTING PARTNERS

SUPPORTING PARTNERS

SUPPORTING PARTNERS